Report Search Results (Showing 1 to 20 of 62)	As of 22-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 11-Nov-09 Roth Capital Partners, Inc. Matt Dolan MELA: 3Q Update: Net Loss Widens Slightly; Likely No MelaFind for Xmas 6 $25     View Abstract 11-Nov-09 Roth Capital Partners, Inc. Matt Dolan EAR: EPS Inline Despite Light Revenue; AARP Coming into View 8 $25     View Abstract 9-Nov-09 Roth Capital Partners, Inc. Matt Dolan 3Q Basically Inline; New Products Drive Growth & Profitability Next Year; Buy 8 $25     View Abstract 9-Nov-09 Roth Capital Partners, Inc. Matt Dolan 3Q Results Light; Future Uncertain Despite Patient Vol; Rating, PT Under Review 4 $10     View Abstract 9-Nov-09 Roth Capital Partners, Inc. Matt Dolan Upgrading to Buy: Coming Out of the Trough with Expanding EPS; Target $15 6 $25     View Abstract 9-Nov-09 Roth Capital Partners, Inc. Matt Dolan OSTE: Another Disappointing Quarter; New Product Success is a Must 8 $25     View Abstract 6-Nov-09 Roth Capital Partners, Inc. Matt Dolan Alphatec (ATEC) 3Q09 Earnings Preview 3 $10     View Abstract 6-Nov-09 Roth Capital Partners, Inc. Matt Dolan Product Revs Essentially Inline; Data & Japan Fuel 2010 Growth, Profit; Buy 8 $25     View Abstract 5-Nov-09 Roth Capital Partners, Inc. Matt Dolan 4Q Picking Back Up; CORTOSS Rollout Progressing, Will Take a Little Time; Buy 8 $25     View Abstract 5-Nov-09 Roth Capital Partners, Inc. Matt Dolan MELA: Approval Equally Probable but Timeline Appears Extended 3 $10     View Abstract 5-Nov-09 Roth Capital Partners, Inc. Matt Dolan 3Q Inline with Preannouncement; Sales Light on Distractions; Call 830AM 3 $10     View Abstract 4-Nov-09 Roth Capital Partners, Inc. Matt Dolan Orthovita Inc. (VITA) 3Q09 Earnings Preview 3 $10     View Abstract 4-Nov-09 Roth Capital Partners, Inc. Matt Dolan Raising Target on DOJ Settlement; 3Q Revs Inline w/ Good Cost Control 8 $25     View Abstract 4-Nov-09 Roth Capital Partners, Inc. Matt Dolan Volcano Corporation (VOLC) 3Q09 Earnings Preview 4 $10     View Abstract 4-Nov-09 Roth Capital Partners, Inc. Matt Dolan Lowering Target: 3Q Messy on Payor Issues; LT Fundamentals Appear Intact 8 $25     View Abstract 4-Nov-09 Roth Capital Partners, Inc. Matt Dolan Bounce Back in 3Q; Rainbow Picking Up; Reiterate Buy 8 $25     View Abstract 3-Nov-09 Roth Capital Partners, Inc. Matt Dolan AtriCure (ATRC) 3Q09 Earnings Preview 3 $10     View Abstract 2-Nov-09 Roth Capital Partners, Inc. Matt Dolan 3Q & FY09 Outlook Beat on All Fronts; 2010 Guidance Possibly Conservative; Buy 8 $25     View Abstract 2-Nov-09 Roth Capital Partners, Inc. Matt Dolan Masimo Corporation (MASI) 3Q09 Earnings Preview 4 $10     View Abstract 2-Nov-09 Roth Capital Partners, Inc. Matt Dolan Clarient, Inc. (CLRT) 3Q09 Earnings Preview 4 $10     View Abstract Next 20